Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2567-2569
doi: 10.1161/CIRCULATIONAHA.107.189726
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2008;117:2567-2569.)
© 2008 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Catheter Ablation for Atrial Fibrillation in Patients With Obesity
 
The present study reports the clinical outcomes of catheter-based ablation (Lasso-guided pulmonary vein isolation or 3-dimensional mapping-guided wide-area pulmonary vein isolation) for symptomatic atrial fibrillation, focusing on an obese patient population. The patients were grouped by body mass index (lean, <25 kg/m2; overweight, 25 to 29.9 kg/m2; obese, ≥30 kg/m2). The vast majority of patients who underwent catheter ablation therapy for symptomatic atrial fibrillation were obese (38%) or overweight (44%). The obese population with atrial fibrillation appears to be more symptomatic with lower Medical Outcomes Study 36-item Short-Form General Health Survey scores for quality of life than lean patients. At the 12-month follow-up, there was no significant difference in atrial fibrillation elimination rate (75%, 72%, and 70% in the lean, overweight, and obese patients, respectively) without the use of antiarrhythmic drugs. The present study conveys that most patients who underwent catheter ablation therapy for symptomatic AF were obese or overweight and provides an encouraging outcome of using catheter ablation in treating patients with obesity and atrial fibrillation. Although weight reduction, an appropriate exercise program, and treatment of hypertension, dyslipidemia, diabetes mellitus, and obstructive sleep apnea are of importance, curative pulmonary vein isolation is a reasonable option in the armamentarium of therapies for obese patients with symptomatic atrial fibrillation. See p 2583.


*    Independent Prognostic Importance of a Restrictive Left Ventricular Filling Pattern After Myocardial Infarction: An Individual Patient Meta-Analysis: Meta-Analysis Research Group in Echocardiography Acute Myocardial Infarction
 
We try to predict the future of our patients with myocardial infarction to improve our understanding of the disease, intervene, and improve the prognosis for individual patients. Echocardiography provides an easily available, attractive tool to . . . [Full Text of this Article]


Related Articles:

Catheter Ablation for Atrial Fibrillation in Patients With Obesity
Yong-Mei Cha, Paul A. Friedman, Samuel J. Asirvatham, Win-Kuang Shen, Thomas M. Munger, Robert F. Rea, Peter A. Brady, Arshad Jahangir, Kristi H. Monahan, David O. Hodge, Ryan A. Meverden, Bernard J. Gersh, Stephen C. Hammill, and Douglas L. Packer
Circulation 2008 117: 2583-2590. [Abstract] [Full Text]

Left Ventricular Morphology and Systolic Function in Sleep-Disordered Breathing: The Sleep Heart Health Study
Hassan A. Chami, Richard B. Devereux, John S. Gottdiener, Reena Mehra, Mary J. Roman, Emelia J. Benjamin, and Daniel J. Gottlieb
Circulation 2008 117: 2599-2607. [Abstract] [Full Text]

Endothelial Dysfunction and Cytomegalovirus Replication in Pediatric Heart Transplantation
Jacob Simmonds, Matthew Fenton, Catherine Dewar, Elizabeth Ellins, Clare Storry, David Cubitt, John Deanfield, Nigel Klein, Julian Halcox, and Michael Burch
Circulation 2008 117: 2657-2661. [Abstract] [Full Text]

Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
Ignatios Ikonomidis, John P. Lekakis, Maria Nikolaou, Ioannis Paraskevaidis, Ioanna Andreadou, Theophania Kaplanoglou, Pelagia Katsimbri, Grigorios Skarantavos, Panayiotis N. Soucacos, and Dimitrios T. Kremastinos
Circulation 2008 117: 2662-2669. [Abstract] [Full Text]

Comparison of Echocardiographic Dyssynchrony Assessment by Tissue Velocity and Strain Imaging in Subjects With or Without Systolic Dysfunction and With or Without Left Bundle-Branch Block
Chinami Miyazaki, Brian D. Powell, Charles J. Bruce, Raul E. Espinosa, Margaret M. Redfield, Fletcher A. Miller, David L. Hayes, Yong-Mei Cha, and Jae K. Oh
Circulation 2008 117: 2617-2625. [Abstract] [Full Text]

Reversal of Cardiac Hypertrophy and Fibrosis From Pressure Overload by Tetrahydrobiopterin: Efficacy of Recoupling Nitric Oxide Synthase as a Therapeutic Strategy
An L. Moens, Eiki Takimoto, Carlo G. Tocchetti, Khalid Chakir, Djahida Bedja, Gianfranco Cormaci, Elizabeth A. Ketner, Maulik Majmudar, Kathleen Gabrielson, Marc K. Halushka, James B. Mitchell, Shyam Biswal, Keith M. Channon, Michael S. Wolin, Nicholas J. Alp, Nazareno Paolocci, Hunter C. Champion, and David A. Kass
Circulation 2008 117: 2626-2636. [Abstract] [Full Text]

Independent Prognostic Importance of a Restrictive Left Ventricular Filling Pattern After Myocardial Infarction: An Individual Patient Meta-Analysis: Meta-Analysis Research Group in Echocardiography Acute Myocardial Infarction
Meta-Analysis Research Group in Echocardiography (MeRGE) AMI Collaborators
Circulation 2008 117: 2591-2598. [Abstract] [Full Text]

Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
Antonio Abbate, Fadi N. Salloum, Elena Vecile, Anindita Das, Nicholas N. Hoke, Stefania Straino, Giuseppe G.L. Biondi-Zoccai, Jon-Erik Houser, Ian Z. Qureshi, Evan D. Ownby, Edoardo Gustini, Luigi M. Biasucci, Anna Severino, Maurizio C. Capogrossi, George W. Vetrovec, Filippo Crea, Alfonso Baldi, Rakesh C. Kukreja, and Aldo Dobrina
Circulation 2008 117: 2670-2683. [Abstract] [Full Text]

Effect of Short Call Admission on Length of Stay and Quality of Care for Acute Decompensated Heart Failure
Jennifer L. Schuberth, Tom A. Elasy, Javed Butler, Robert Greevy, Theodore Speroff, Robert S. Dittus, and Christianne L. Roumie
Circulation 2008 117: 2637-2644. [Abstract] [Full Text]

Results of the Predictors of Response to CRT (PROSPECT) Trial
Eugene S. Chung, Angel R. Leon, Luigi Tavazzi, Jing-Ping Sun, Petros Nihoyannopoulos, John Merlino, William T. Abraham, Stefano Ghio, Christophe Leclercq, Jeroen J. Bax, Cheuk-Man Yu, John Gorcsan, III, Martin St John Sutton, Johan De Sutter, and Jaime Murillo
Circulation 2008 117: 2608-2616. [Abstract] [Full Text]

Novel Role for Inhibitor of Differentiation 2 in the Genesis of Angiotensin II–Induced Hypertension
Petra Gratze, Ralf Dechend, Carolin Stocker, Joon-Keun Park, Sandra Feldt, Erdenechimeg Shagdarsuren, Maren Wellner, Faikah Gueler, Song Rong, Volkmar Gross, Michael Obst, Ralph Plehm, Natalia Alenina, Ana Zenclussen, Jens Titze, Kersten Small, Yoshifumi Yokota, Martin Zenke, Friedrich C. Luft, and Dominik N. Muller
Circulation 2008 117: 2645-2656. [Abstract] [Full Text]